Highlighted Reports in European Lung Cancer Conference1
Challenges in the treatment of early non-small cell lung cancer: what is the standard, what are the challenges and what is the future for radiotherapy?
Translational Lung Cancer Research
2014;
3
(4)
:195-204
.
(28 August 2014)
Molecular epidemiology of lung cancer and geographic variations with special reference to EGFR mutations
Translational Lung Cancer Research
2014;
3
(4)
:205-211
.
(28 August 2014)
SBRT in operable early stage lung cancer patients
Translational Lung Cancer Research
2014;
3
(4)
:212-224
.
(28 August 2014)
Preoperative mediastinal lymph node staging for non-small cell lung cancer: 2014 update of the 2007 ESTS guidelines
Translational Lung Cancer Research
2014;
3
(4)
:225-233
.
(28 August 2014)
Radiotherapy for single station N2 NSCLC
Translational Lung Cancer Research
2014;
3
(4)
:234-237
.
(28 August 2014)
Editorial
An alternative way to initiate Notch1 signaling in non-small cell lung cancer
Translational Lung Cancer Research
2014;
3
(4)
:238-241
.
(28 August 2014)
Review Article
Recurrence after surgery in patients with NSCLC
Translational Lung Cancer Research
2014;
3
(4)
:242-249
.
(28 August 2014)
ALK and crizotinib: after the honeymoon…what else? Resistance mechanisms and new therapies to overcome it
Translational Lung Cancer Research
2014;
3
(4)
:250-261
.
(28 August 2014)
Case Report
Coexistent pulmonary granular cell tumor and adenocarcinoma of the lung
Translational Lung Cancer Research
2014;
3
(4)
:262-264
.
(28 August 2014)
Meet the Professor2
Gavin M. Wright: Current treatments for NSCLC
Translational Lung Cancer Research
2014;
3
(4)
:265-266
.
(28 August 2014)
Meeting Report
94th Annual Meeting of the American Association for Thoracic Surgery (AATS) seen through thoracic surgical glasses
Translational Lung Cancer Research
2014;
3
(4)
:267-268
.
(28 August 2014)
Disclosure:
1. The series “Highlighted Reports in European Lung Cancer Conference” was commissioned by the Editorial office, Translational Lung Cancer Research without any sponsorship or funding.
2. The series “Meet the Professor” was commissioned by the Editorial office, Translational Lung Cancer Research without any sponsorship or funding.
